CIK 0001850270 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
PROKIDNEY CORP.
Sign in to watch- Ticker
- PROK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- EIN
- 981586514
- Phone
- 336-999-7028
- Business address
- 2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
- Former names
- Social Capital Suvretta Holdings Corp. III
- 8-K/A Event Executive or director change
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- 8-K Event Executive or director change
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 4 Open-market sale Former 10% Owner sold 7,256,367 shares at $1.31 ($9,498,584)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Regulation FD disclosure
- 4 Open-market sale 10% owner sold 752,800 shares at an average $1.31 ($987,946)
- 4 Open-market sale 10% owner sold 576,700 shares at an average $1.56 ($897,872)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- 4 Open-market sale 10% owner sold 209,833 shares at an average $1.60 ($334,948)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 405,400 shares at an average $1.70 ($688,100)
- SC 13D Stake Beneficial Ownership Report
- 4 Conversion Director acquired 5,289,055 shares (conversion)
Page 10 of 21 · 406 filings